FR2573652B1 - Composition aqueuse de cromoglycate de sodium - Google Patents

Composition aqueuse de cromoglycate de sodium

Info

Publication number
FR2573652B1
FR2573652B1 FR8517331A FR8517331A FR2573652B1 FR 2573652 B1 FR2573652 B1 FR 2573652B1 FR 8517331 A FR8517331 A FR 8517331A FR 8517331 A FR8517331 A FR 8517331A FR 2573652 B1 FR2573652 B1 FR 2573652B1
Authority
FR
France
Prior art keywords
sodium cromoglycate
aqueous composition
formulation
cromoglycate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8517331A
Other languages
English (en)
Other versions
FR2573652A1 (fr
Inventor
Emmett Clemente
Vincent Hon-Kin Li
Henry Pfeifer
Joseph Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24706028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2573652(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2573652A1 publication Critical patent/FR2573652A1/fr
Application granted granted Critical
Publication of FR2573652B1 publication Critical patent/FR2573652B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FR8517331A 1984-11-23 1985-11-22 Composition aqueuse de cromoglycate de sodium Expired FR2573652B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67428284A 1984-11-23 1984-11-23

Publications (2)

Publication Number Publication Date
FR2573652A1 FR2573652A1 (fr) 1986-05-30
FR2573652B1 true FR2573652B1 (fr) 1988-09-02

Family

ID=24706028

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8517331A Expired FR2573652B1 (fr) 1984-11-23 1985-11-22 Composition aqueuse de cromoglycate de sodium

Country Status (18)

Country Link
EP (1) EP0183457B1 (fr)
JP (1) JPH0639379B2 (fr)
AT (1) ATE71524T1 (fr)
AU (2) AU4999785A (fr)
BE (1) BE903701A (fr)
CA (1) CA1267848A (fr)
CH (1) CH666816A5 (fr)
DE (1) DE3585211D1 (fr)
DK (1) DK541285A (fr)
FR (1) FR2573652B1 (fr)
GB (1) GB2167300B (fr)
GR (1) GR852791B (fr)
IE (1) IE59195B1 (fr)
IL (1) IL77086A0 (fr)
LU (1) LU86172A1 (fr)
NZ (1) NZ214295A (fr)
PT (1) PT81538A (fr)
ZA (1) ZA858914B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1317226C (fr) * 1987-05-04 1993-05-04 Phillip E. Pennell Liquide visco-elastique pour chirurgie ophtalmique et methode d'utilisation
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
EP0444778A1 (fr) * 1990-02-14 1991-09-04 Alcon Laboratories, Inc. Utilisation d'alkylsaccharides pour augmenter la pénétration de médicaments
DE19539532C2 (de) * 1995-10-24 1999-02-25 Mann Gerhard Chem Pharm Fab Ophthalmisches Cromoglicat-Gelpräparat
WO2000042986A2 (fr) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Liquide lacrymal artificiel en gel
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
JP5364658B2 (ja) * 2000-07-21 2013-12-11 ロート製薬株式会社 点眼剤
WO2005003111A1 (fr) * 2003-07-04 2005-01-13 Astellas Pharma Inc. Agent de prevention ou de traitement de la conjonctivite virale
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
ES2457442T3 (es) * 2009-05-08 2014-04-25 Pari Pharma Gmbh Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
JP2013231185A (ja) * 2013-06-12 2013-11-14 Pfizer Products Inc ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
US20160367520A1 (en) 2014-02-10 2016-12-22 Patara Pharma, LLC Mast cell stabilizers for lung disease treatment
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
WO2017027402A1 (fr) 2015-08-07 2017-02-16 Patara Pharma, LLC Méthodes de traitement de troubles systémiques aptes à être traités par des stabilisateurs de mastocytes, y compris de troubles liés aux mastocytes
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
CN109803724A (zh) 2016-10-07 2019-05-24 瑞思皮万特科学有限责任公司 用于治疗肺纤维化的色甘酸组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
IE41922B1 (en) * 1974-11-09 1980-04-23 Fisons Ltd Pharmaceutical compositions containing bis-chromones
US4268519A (en) * 1979-06-05 1981-05-19 Fisons Limited Method of treating otitis media
JPS5756448A (en) * 1980-09-22 1982-04-05 Mitsui Toatsu Chem Inc Preparation of aromatic isocyanate

Also Published As

Publication number Publication date
IL77086A0 (en) 1986-04-29
AU4431189A (en) 1990-02-22
IE852942L (en) 1986-05-23
GB2167300B (en) 1988-11-23
JPS61143318A (ja) 1986-07-01
BE903701A (fr) 1986-05-22
CH666816A5 (fr) 1988-08-31
GB2167300A (en) 1986-05-29
NZ214295A (en) 1988-07-28
EP0183457A3 (en) 1987-04-15
JPH0639379B2 (ja) 1994-05-25
AU4999785A (en) 1986-05-29
DE3585211D1 (de) 1992-02-27
DK541285D0 (da) 1985-11-22
CA1267848A (fr) 1990-04-17
IE59195B1 (en) 1994-01-26
GB8528190D0 (en) 1985-12-18
FR2573652A1 (fr) 1986-05-30
LU86172A1 (fr) 1986-03-24
PT81538A (en) 1985-12-01
EP0183457A2 (fr) 1986-06-04
GR852791B (fr) 1986-03-21
ZA858914B (en) 1987-07-29
EP0183457B1 (fr) 1992-01-15
ATE71524T1 (de) 1992-02-15
DK541285A (da) 1986-05-24

Similar Documents

Publication Publication Date Title
FR2573652B1 (fr) Composition aqueuse de cromoglycate de sodium
FI942573A (fi) Koostumus, joka käsittää hyytymistekijä VIII -formuloinnin, sen valmistusmenetelmä ja pinta-aktiivisen aineen käyttö stabilointiaineena
PT89520B (pt) Processo para a preparacao de derivados de quinolino e acido naftiridino-carboxilicos substituidos por alquilo na posicao 5 e substituidos por um anel de piperazina ou pirrolidina na posicao 7 e de composicoes farmaceuticas que os contem
ES2078291T3 (es) Nuevos derivados de acido a-nor-esteroide-3-carboxilico.
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ATE78691T1 (de) Sucralfat-suspension zur verwendung in der behandlung von geschwueren.
EP0363469A4 (en) Lacrimal secretion stimulant (lss)
BR9205400A (pt) Composições corantes de enxofre e sua produção.
NO871663D0 (no) Adhesiver avledet fra bioadhesive polyfenoliske proteiner.
YU46561B (sh) Postupak za stabilizaciju vodenog rastvora ranitidina
DE3868892D1 (de) Verwendung von bisguanide enthaltenden zusammensetzungen gegen eier des madenwurms.
DE68904462D1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelial-gewebekrankheiten.
PT83478A (de) Neue polyoxygenierte labdan-derivate verfahren zur ihrer herstellung und ihre anwendung als medikamente
ATE81144T1 (de) Bohnerwachszusammensetzung.
BR8807325A (pt) Polieteruretana,processo para sua preparacao,agentes auxiliares de processamento e aplicacao da polieteruretana
DE69002697D1 (de) Carboplatinzusammensetzung.
SE8801710L (sv) New ophtalmological composition of matter
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
BR8106153A (pt) Processo para a concentracao de uma solucao aquosa viscosa de um polissacarideo solucao aquosa concentrada processo para preparacao de uma solucao de polissacarideos e processo para deslocamento de um fluido atraves de um poco
CA2046601A1 (fr) Production et utilisation d'agents vermifuges et d'immunogenes protecteurs
PT93915A (pt) Processo para a preparacao de novos derivados de 4-fenil-metil-1h-indol e de composicoes farmaceuticas que os contem
PT90696A (pt) Processo de preparacao de novos compostos tri-iodobenzenicos nao ionicos e de produtos de contraste que os contem
ES2085833B1 (es) Derivados de carboximetilidencicloheptimidazol y metodo para prepararlos.
SE8404130D0 (sv) New injectable compositions
IT1215319B (it) Formulazione acquosa di sodio cromo glicato con viscosita' compresa fra 2 e 300 mpa.s e metodo per prepararla

Legal Events

Date Code Title Description
ST Notification of lapse